| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/30/2011 | US8008290 Compounds |
| 08/30/2011 | US8008289 α-aminocyclolactam ligands for G-protein coupled receptors |
| 08/30/2011 | US8008288 Anti-inflammatory A-aminocyclolactam compounds |
| 08/30/2011 | US8008287 Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one |
| 08/30/2011 | US8008286 Method for treatment of neuropathic pain |
| 08/30/2011 | US8008285 Chronic pain, allodynia, hyperalgesia, fatigue, sleep disturbance, and depression; Central Sensitivity Syndrome; kits |
| 08/30/2011 | US8008282 Lipoxin analogs as novel inhibitors of angiogenesis |
| 08/30/2011 | US8008281 Methods for the treatment of cancer |
| 08/30/2011 | US8008280 Betulinol derivatives as anti-HIV agents |
| 08/30/2011 | US8008278 Diarylmethyl and related compounds |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008275 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use |
| 08/30/2011 | US8008274 P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis |
| 08/30/2011 | US8008272 Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon |
| 08/30/2011 | US8008271 Methods and compositions for treating gain-of-function disorders using RNA interference |
| 08/30/2011 | US8008270 Antiviral oligonucleotides targeting viral families |
| 08/30/2011 | US8008269 Antiviral oligonucleotides |
| 08/30/2011 | US8008267 Modified dinucleotides for reduce or improve immunostimulatory; genetic vaccines; cancer vaccines |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008265 Vaccines, immunotherapeutics and methods for using the same |
| 08/30/2011 | US8008264 1′-substituted carba-nucleoside analogs for antiviral treatment |
| 08/30/2011 | US8008258 Cop 1 for treatment of inflammatory bowel diseases |
| 08/30/2011 | US8008250 Macrocyclic compounds and compositions useful as BACE inhibitors |
| 08/30/2011 | US8008239 Acylalkylisethionate esters and applications in consumer products |
| 08/30/2011 | US8008078 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 08/30/2011 | US8008077 Photochemical internalization for delivery of molecules into the cytosol |
| 08/30/2011 | US8008076 Method of producing a nucleic acid encoding an antibody |
| 08/30/2011 | US8008004 Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| 08/30/2011 | US8007853 Vitamin/mineral composition with DHA |
| 08/30/2011 | US8007832 Cancer treatment |
| 08/30/2011 | US8007831 Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
| 08/30/2011 | US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing |
| 08/30/2011 | US8007826 Sustained release aminopyridine composition |
| 08/30/2011 | US8007825 Oral compositions containing a salivation inducing agent |
| 08/30/2011 | US8007824 solid oral dosage form comprising about 83 to 332 mg of aliskiren or a hemi-fumarate salt thereof; in vitro dissolution profile of more than 46% by weight of the oral dosage form; renin inhibitor; antihypertensives for treating congestive heart failure; industrial scale manufacture |
| 08/30/2011 | US8007821 Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with microstructured surface |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 08/30/2011 | US8007775 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
| 08/30/2011 | US8007771 Flavors for oral compositions |
| 08/30/2011 | US8007752 Process for preparing oral calcium compositions |
| 08/30/2011 | CA2672256C Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide |
| 08/30/2011 | CA2666871C Long term feed - cancer patient |
| 08/30/2011 | CA2645294C Dibenzyl amine compounds and derivatives |
| 08/30/2011 | CA2566496C Pharmaceutical compositions and methods for peptide treatment |
| 08/30/2011 | CA2552600C Triaza-cyclopenta[cd]indene derivatives |
| 08/30/2011 | CA2542813C Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivatives, process and drugs containing these compounds |
| 08/30/2011 | CA2536401C Compositions of quaternary ammonium compounds containing bioavailability enhancers |
| 08/30/2011 | CA2526852C Use of 2h- [1,3] - oxazino [3,2-a] indole derivatives for the treatment of neuropathic pain |
| 08/30/2011 | CA2526052C Use of indazole derivatives for the treatment of neuropathic pain |
| 08/30/2011 | CA2508832C Device and patch for controlled release of vanillin |
| 08/30/2011 | CA2503286C Compounds for the treatment of tobacco dependence and withdrawal |
| 08/30/2011 | CA2493883C Drugs for improving the prognosis of brain injury and a method of screening the same |
| 08/30/2011 | CA2492021C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/30/2011 | CA2486298C Means for weaning people off smoking and alcohol |
| 08/30/2011 | CA2479665C Nanoparticulate compositions of angiogenesis inhibitors |
| 08/30/2011 | CA2474608C Topical compositions comprising a plant extract for skin irritation or improvement of skin appearance |
| 08/30/2011 | CA2472293C Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 08/30/2011 | CA2468965C Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
| 08/30/2011 | CA2460911C 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 08/30/2011 | CA2459757C Combination |
| 08/30/2011 | CA2458172C Coated medical devices |
| 08/30/2011 | CA2442577C Cell separation compositions and methods |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2438717C 6-phenylbenzonaphthyridines |
| 08/30/2011 | CA2415927C Dietary lipids for improving skin and coat of pets |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/30/2011 | CA2378893C In vivo induction for enhanced function of isolated hepatocytes |
| 08/30/2011 | CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/30/2011 | CA2362268C Novel substance derived from basidiomycetes culture, method for producing it and its use |
| 08/30/2011 | CA2359967C Method for preparing an aza-macrolide with 4"(r)nh2 |
| 08/30/2011 | CA2270531C A method for treating tension-type headache |
| 08/30/2011 | CA2251647C Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/25/2011 | WO2011103586A2 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine |
| 08/25/2011 | WO2011103557A1 Small molecule inhibitors of pfkfb3 and glycolytic flux and their methods of use as anti-cancer therapeutics |
| 08/25/2011 | WO2011103546A1 Triazolones as fatty acid synthase inhibitors |
| 08/25/2011 | WO2011103536A1 Multifunctional radical quenchers and their use |
| 08/25/2011 | WO2011103531A1 Method for Activation and Conjugation of Biomolecules |
| 08/25/2011 | WO2011103528A2 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 08/25/2011 | WO2011103524A2 Cyclic tetrapeptides and therapeutic applications thereof |
| 08/25/2011 | WO2011103516A2 Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals |
| 08/25/2011 | WO2011103512A1 Dha free fatty acid emulsions |
| 08/25/2011 | WO2011103510A1 Dha ester emulsions |
| 08/25/2011 | WO2011103509A1 Heterocyclic compounds and uses as anticancer agents |
| 08/25/2011 | WO2011103485A1 Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| 08/25/2011 | WO2011103460A1 Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use |
| 08/25/2011 | WO2011103457A1 Pyrimidine derivatives |
| 08/25/2011 | WO2011103441A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 08/25/2011 | WO2011103433A1 Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| 08/25/2011 | WO2011103430A1 Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| 08/25/2011 | WO2011103423A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 08/25/2011 | WO2011103413A2 Taxane pro-emulsion formulations and methods making and using the same |
| 08/25/2011 | WO2011103345A2 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor |
| 08/25/2011 | WO2011103321A1 Novel bexarotene analogs |
| 08/25/2011 | WO2011103289A2 Imidazole-2, 4-dione inhibitors of casein kinase 1 |
| 08/25/2011 | WO2011103256A1 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
| 08/25/2011 | WO2011103246A1 Methods for treating infection |
| 08/25/2011 | WO2011103242A1 Neuregulin antagonists and use thereof in treating cancer |
| 08/25/2011 | WO2011103202A2 Androgen receptor modulators and uses thereof |